Biofrontera Inc. (Nasdaq:BFRI)

Health Care/Life Sciences • Pharmaceuticals

CIK 1858685

Company

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Address
120 Presidnetial Way
Suite 330
Woburn, Massachusetts 01801

Employees
85

Stock Info

Close
$0.8443

Day Range
0.8400 - 0.9139

52 Week Range
0.6513 - 2.4302

Average volume
569.47K

Short Interest
165.54K (02/14/25)

% of Float Shorted
2.26%

Market Cap
$7.81M

Revenue
$34.07M

Net Income
-$20.13M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$2.2652

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman & Chief Executive Officer
Hermann Lübbert

Director
Heikki Lanckriet

Independent Director
Kevin D. Weber

Independent Director
John J. Borer III

Independent Director
Beth J. Hoffman

SEC filings

Date	Form	Event
20 Dec, 2024	SCHEDULE 1
5 Dec, 2024	D
27 Nov, 2024	8-K
22 Nov, 2024	8-K
14 Nov, 2024	10-Q
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
13 Nov, 2024	SC 13G/A
13 Nov, 2024	8-K
13 Nov, 2024	S-8
6 Nov, 2024	SC 13G/A
1 Nov, 2024	SC 13G/A
31 Oct, 2024	8-K
23 Oct, 2024	SC 13G/A
7 Oct, 2024	8-K
12 Sep, 2024	SC 13G
14 Aug, 2024	8-K
14 Aug, 2024	10-Q
16 Jul, 2024	4
16 Jul, 2024	4
16 Jul, 2024	4
16 Jul, 2024	4
16 Jul, 2024	4
16 Jul, 2024	4
24 Jun, 2024	8-K
14 Jun, 2024	8-K
29 May, 2024	SC 13G/A
22 May, 2024	8-K
22 May, 2024	4
15 May, 2024	8-K
15 May, 2024	10-Q
9 May, 2024	EFFECT
8 May, 2024	CORRESP
8 May, 2024	UPLOAD
7 May, 2024	SC 13G
3 May, 2024	8-K
3 May, 2024	S-1
30 Apr, 2024	8-K
30 Apr, 2024	DEFR14A
25 Apr, 2024	8-K
22 Apr, 2024	CORRESP
22 Apr, 2024	EFFECT
17 Apr, 2024	DEF 14A
3 Apr, 2024	8-K/A
26 Mar, 2024	8-K
21 Mar, 2024	DEF 14A
20 Mar, 2024	SC 13G
20 Mar, 2024	SC 13G
20 Mar, 2024	S-1/A
20 Mar, 2024	SC 13G
20 Mar, 2024	SC 13G
18 Mar, 2024	UPLOAD
15 Mar, 2024	10-K
15 Mar, 2024	SC 13G
15 Mar, 2024	8-K
11 Mar, 2024	S-1
8 Mar, 2024	PRE 14A
5 Mar, 2024	D
23 Feb, 2024	8-K
20 Feb, 2024	8-K
20 Feb, 2024	RW
14 Feb, 2024	SC 13G
13 Feb, 2024	8-K
5 Feb, 2024	8-K
2 Feb, 2024	8-K
29 Jan, 2024	S-1/A
25 Jan, 2024	8-K
17 Jan, 2024	S-1
11 Jan, 2024	8-K
9 Jan, 2024	8-K/A
3 Jan, 2024	8-K
28 Dec, 2023	8-K
27 Dec, 2023	8-K
15 Dec, 2023	8-K
29 Nov, 2023	8-K
17 Nov, 2023	DEF 14A
9 Nov, 2023	8-K
9 Nov, 2023	10-Q
2 Nov, 2023	8-K
1 Nov, 2023	424B4
30 Oct, 2023	EFFECT
27 Oct, 2023	S-1/A
27 Oct, 2023	CORRESP
16 Oct, 2023	S-1/A
13 Oct, 2023	8-K
13 Oct, 2023	CORRESP
11 Oct, 2023	UPLOAD
10 Oct, 2023	8-K
5 Oct, 2023	S-1
4 Oct, 2023	8-K
3 Oct, 2023	8-K
22 Aug, 2023	3
11 Aug, 2023	10-Q
11 Aug, 2023	8-K
13 Jul, 2023	8-K
12 Jul, 2023	8-K
3 Jul, 2023	8-K
2 Jun, 2023	8-K
1 Jun, 2023	8-K
30 May, 2023	8-K
26 May, 2023	8-K	CEO Change
22 May, 2023	4
22 May, 2023	4
12 May, 2023	8-K	CEO Change
12 May, 2023	10-Q
28 Apr, 2023	8-A12B/A
28 Apr, 2023	8-K
21 Apr, 2023	DEF 14A
17 Apr, 2023	8-K
11 Apr, 2023	PRE 14A
13 Mar, 2023	10-K
8 Mar, 2023	8-K
2 Mar, 2023	8-K
12 Jan, 2023	4
12 Jan, 2023	4
9 Jan, 2023	8-K
16 Dec, 2022	8-K
8 Dec, 2022	DEFA14A
29 Nov, 2022	DEFA14A
21 Nov, 2022	DEFA14A
15 Nov, 2022	424B3
15 Nov, 2022	424B3
14 Nov, 2022	8-K
14 Nov, 2022	10-Q
14 Nov, 2022	DEFR14A
9 Nov, 2022	8-K
8 Nov, 2022	DEF 14A
7 Nov, 2022	EFFECT
4 Nov, 2022	D
4 Nov, 2022	SC 13G
4 Nov, 2022	3
3 Nov, 2022	S-1
3 Nov, 2022	CORRESP
31 Oct, 2022	8-K
24 Oct, 2022	8-K
14 Oct, 2022	8-A12B
14 Oct, 2022	8-K
5 Oct, 2022	8-K
19 Sep, 2022	4
19 Sep, 2022	SC 13D/A
19 Sep, 2022	4
30 Aug, 2022	UPLOAD
29 Aug, 2022	DRS
26 Aug, 2022	DRSLTR
25 Aug, 2022	SC 13D
12 Aug, 2022	10-Q
12 Aug, 2022	8-K
11 Aug, 2022	D
28 Jul, 2022	8-K
12 Jul, 2022	8-K
13 Jun, 2022	EFFECT
10 Jun, 2022	POS AM
9 Jun, 2022	424B3
9 Jun, 2022	EFFECT
7 Jun, 2022	S-8
7 Jun, 2022	S-1
7 Jun, 2022	CORRESP
6 Jun, 2022	4/A
6 Jun, 2022	4/A
6 Jun, 2022	4/A
6 Jun, 2022	4/A
1 Jun, 2022	UPLOAD
27 May, 2022	DRSLTR
27 May, 2022	DRS
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
24 May, 2022	8-K
24 May, 2022	8-K/A
23 May, 2022	D
20 May, 2022	8-K
13 May, 2022	424B3
13 May, 2022	8-K
13 May, 2022	424B3
13 May, 2022	10-Q
11 Apr, 2022	POS EX
11 Apr, 2022	10-K
11 Apr, 2022	POS EX
11 Apr, 2022	424B3
11 Apr, 2022	424B3
8 Apr, 2022	8-K
6 Apr, 2022	8-K
5 Apr, 2022	8-K
1 Apr, 2022	NT 10-K
14 Mar, 2022	3
8 Mar, 2022	8-K
10 Feb, 2022	SC 13G
19 Jan, 2022	4/A
19 Jan, 2022	4/A
19 Jan, 2022	4
13 Jan, 2022	8-K
29 Dec, 2021	8-K
23 Dec, 2021	EFFECT
23 Dec, 2021	424B3
21 Dec, 2021	S-1
21 Dec, 2021	CORRESP
16 Dec, 2021	UPLOAD
14 Dec, 2021	DRSLTR
14 Dec, 2021	DRS
13 Dec, 2021	4
13 Dec, 2021	4
10 Dec, 2021	D
3 Dec, 2021	8-K
30 Nov, 2021	8-K
30 Nov, 2021	10-Q
29 Nov, 2021	8-K
3 Nov, 2021	8-K
2 Nov, 2021	3
2 Nov, 2021	3
2 Nov, 2021	3
1 Nov, 2021	424B4	IPO completed
29 Oct, 2021	FWP
28 Oct, 2021	3
28 Oct, 2021	CERT
28 Oct, 2021	EFFECT
28 Oct, 2021	SEC STAFF
28 Oct, 2021	3
28 Oct, 2021	3
28 Oct, 2021	3
27 Oct, 2021	CORRESP
27 Oct, 2021	8-A12B/A
27 Oct, 2021	CORRESP
26 Oct, 2021	S-1/A
20 Oct, 2021	CORRESP
20 Oct, 2021	8-A12B
20 Oct, 2021	CORRESP
19 Oct, 2021	S-1/A
18 Oct, 2021	CORRESP
18 Oct, 2021	CORRESP
15 Oct, 2021	S-1/A
14 Oct, 2021	UPLOAD
14 Oct, 2021	CORRESP
14 Oct, 2021	S-1/A
13 Oct, 2021	CORRESP
13 Oct, 2021	CORRESP
13 Oct, 2021	S-1/A
13 Oct, 2021	CORRESP
12 Oct, 2021	UPLOAD
12 Oct, 2021	S-1/A
8 Oct, 2021	CORRESP
8 Oct, 2021	CORRESP
8 Oct, 2021	CORRESP
7 Oct, 2021	UPLOAD
1 Oct, 2021	S-1/A
1 Oct, 2021	FWP
17 Sep, 2021	SEC STAFF
16 Sep, 2021	S-1/A
15 Sep, 2021	CORRESP
9 Sep, 2021	UPLOAD
31 Aug, 2021	S-1/A
30 Aug, 2021	CORRESP
20 Aug, 2021	UPLOAD
12 Aug, 2021	S-1/A
11 Aug, 2021	CORRESP
2 Aug, 2021	UPLOAD
26 Jul, 2021	S-1/A
23 Jul, 2021	CORRESP
19 Jul, 2021	UPLOAD
6 Jul, 2021	S-1
6 Jul, 2021	CORRESP
1 Jul, 2021	UPLOAD
22 Jun, 2021	DRS/A
21 Jun, 2021	DRSLTR
10 Jun, 2021	UPLOAD
11 May, 2021	DRS/A
7 May, 2021	DRS

Last update:2025-03-06 13:08:06.657097

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.